4Heeba G, Moselhy ME, Hassan M, et al. Anti - atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase -1 [ J] . Br J Pharmacol, 2009,156 ( 8 ) : 1256 - 1266.
5Amin KA, Abd E1 -Twab TM.. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats : role of atorvastatine and cinnamon[ J]. Int J Clin Exp Med, 2009,2( 3 ), 254 -265.
6Igarashi J, Miyoshi M, Hashimoto T, et al. Statins induce S1PI receptors and enhance endothelial nitric oxide production in response to high - density lipopreteins [ J ]. Br J Pharmacol, 2007, 150 (4) : 470 - 479.
7Merla R, Ye YM, Lin Y, et al. The central role of adenosine in sta- tin - induced ERK1/2, Akt, and eNOS phosphorylation [ J ]. Am J Physiol Heart Circ Physiol, 2007,293(3) : H1918 -1928.
9Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the devel opment of atheroselerotic lesions in apolipoprotein E knockout mice [J]. Arterioscler Thromb Vase Biol, 2009,29(2) : 173 -179.
10Liu YH, Yah CD, Bian JS. Hydrogen sulfide : a novel signaling mol- ecule in the vascular system [ J ]. J Cardiovase Pharmaeol, 2011 Jan 28, [ Epub ahead of print].
8Behr - Roussel D, Rupin A, Simonet S, et al. Effect of chronictreatment with the inducible nitric oxide synthase inhibitor N -iminoethyl - L - lysine or with L - arginine on progression of coro-nary and aortic atherosclerosis in hypercholesterolemic rabbits [J].Circulation,2000,102(9): 1 033 - 1 038.
9Hong HJ, Loh SH, Yen MH. Suppression of the developmentof hypertension by the inhibitor of inducible nitric oxide syn-thase [J]. Br J Pharmacol,2000,131 (3) : 631 - 637.
10Li YC,Luo Q,Ge LS,et al. Ivabradine inhibits the production ofproinflammatory cytokines and inducible nitric oxide synthase inacute coxsackievirus B3 - induced myocarditis [J]. Biochem Bio-phys Res Gommun,2013 ,431 (3): 450 - 455.
